Lack of interaction of digoxin and P-glycoprotein inhibitors, quinidine and verapamil in human placenta in vitro
Authors:
- Gershon HolcbergGHGershon Holcberg
- Olga SapirOSOlga Sapir
- Marina TsadkinMTMarina Tsadkin
- Mahmoud HuleihelMahmoud Huleihel
- Simcha LazerSLSimcha Lazer
- Miriam KatzMKMiriam Katz
- Moshe MazorMMMoshe Mazor
- Zvi Ben-ZviZBZvi Ben-Zvi
- 1 August 2003
- journal article
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 109 (2) , 133-137
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Human placental transport of vinblastine, vincristine, digoxin and progesterone: contribution of P-glycoproteinEuropean Journal of Pharmacology, 2000
- P-GLYCOPROTEIN SYSTEM AS A DETERMINANT OF DRUG INTERACTIONS: THE CASE OF DIGOXIN–VERAPAMILPharmacological Research, 1999
- Inhibition of P-Glycoprotein–Mediated Drug TransportCirculation, 1999
- Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in miceReproductive Toxicology, 1998
- Function of P-Glycoprotein Expressed in Placenta and MoleBiochemical and Biophysical Research Communications, 1997
- Placental Transfer of Drugs Administered to the MotherClinical Pharmacokinetics, 1995
- Dual in vitro Perfusion of an Isolated Lobe of Human Placenta: Method and Instrumentation1985
- Digoxin-verapamil interactionClinical Pharmacology & Therapeutics, 1981
- Successful Treatment of Fetal Congestive Heart Failure Secondary to TachycardiaNew England Journal of Medicine, 1981
- Effects of Quinidine on Serum Digoxin ConcentrationAnnals of Internal Medicine, 1980